Llwytho...
Targeting prenylation inhibition through the mevalonate pathway
Protein prenylation is a critical mediator in several diseases including cancer and acquired immunodeficiency syndrome (AIDS). Therapeutic intervention has focused primarily on directly targeting the prenyltransferase enzymes, FTase and GGTase I and II. To date, several drugs have advanced to clinic...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | RSC Med Chem |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Royal Society of Chemistry
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485146/ https://ncbi.nlm.nih.gov/pubmed/33479604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c9md00442d |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|